Highlights Pharma Mar, S.A.

Equities

PHM

ES0169501022

Real-time Estimate Tradegate Other stock markets 12:55:55 09/05/2024 BST			5-day change	1st Jan Change
31.76 ^EUR	-0.06%		+2.72%	-22.69%

04-23	Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-29	Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23	CI
Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
Pharma Mar Partner Wins Approval for Lung Cancer Drug in Macao	12-04	MT
Pharma Mar's Partner Wins Commercialization Approval for Zepzelca in Peru	11-07	MT
Pharma Mar, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Pharma Mar, S.A. commences an Equity Buyback Plan, under the authorization approved on May 31, 2023.	05/09/23	CI
Pharma Mar, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	27/07/23	CI
Ex-dividend day for final dividend	06/06/23	FA
Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Pharma Mar Wins Conditional Approval For Lung Cancer Drug In Israel	31/01/23	MT
Pharma Mar, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Klaria Pharma, Pharma Mar to Collaborate on Feasibility Study	07/10/22	MT
Pharma Mar's Partner Wins Conditional Marketing Nod In South Korea For Small Cell Lung Cancer Drug	23/09/22	MT
Pharma Mar, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	27/07/22	CI
Pharma Mar, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	27/07/22	CI
Ex-dividend day for final dividend	12/07/22	FA
Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22	CI
Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	01/03/22	CI
Spain's PharmaMar raises dividend despite 32% drop in 2021 profit	28/02/22	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pharma Mar, S.A.

Equities

PHM

ES0169501022

Highlights

Filters